Pristina Duo

Reach more, care more with Pristina DuoTM — your trusted partner in breast care.
At a glance

Wide reach. Deep impact.

Built to expand screening programs and increase access for early detection

Supercharge productivity

Engineered to enhance accuracy1 and drive high patient throughput

Comfort in every scan

Thoughtfully designed to help make mammograms easy and less anxiety3

Affordable innovation

Made to deliver modern, next-generation technology with real-world pricing

Pristina Duo helps you bring essential breast care to more patients, in more places.

Built on the Senographe PristinaTM platform, Pristina Duo is more than a mammography system — it’s your trusted partner. It works with you to enhance accuracy1 and save time2, driving patient throughput, productivity, and long-term value. Made with women in mind, the platform prioritizes comfort. With Pristina Duo by your side, reach more and care more. Expand screening programs and increase access to care.
PERFORMANCE THAT LASTS

Your partner to maximize your investment

The system is designed to efficiently manage a high number of patients, enhancing the benefit of each exam—delivering the performance and value your team depends on.

• 96% of users believing that the Senographe Pristina Platform facilitated faster image acquisition compared to previous system.2
• Potential to image up to 150 patients a day.4
• 64% of the technologists agreed that the system enabled an increase in the number of exam completed per day compared to their previous system.2
• An affordable screening solution completes with tailored financial options to suit your needs.  
• The Senographe Pristina platform provides exceptional reliability with Pristina systems demonstrating a 99% uptime.5

MORE EASE. LESS STRESS

Your partner for patient comfort and care

Pristina Duo makes mammography a more positive experience3. From comfort-driven design to easier positioning, it helps reduce anxiety3 and shift perceptions— helping motivate patients to return for regular mammograms.

• 97% of patients reported feeling less anxious or not anxious at all thanks to the gantry design.3
• 70% of patients rated the system more comfortable than previous system.3
• 83% of patients would like their next exam to be on the Senographe Pristina platform.6
• 82% of technologists surveyed felt that the design of the Senographe Pristina Platform enabled easier patient positioning compared to their previous systems.2
• Senographe Pristina Platform 3D STD mode having the lowest dose for all thicknesses among the major systems available in the marketplace.7

SUPPORTS CLEAR ANSWERS

Your partner for clinical confidence

Confidence starts with clarity. Pristina Duo delivers exceptional image quality, which can improve accuracy1 and help limit recalls8—enabling earlier, decisive cancer detection.

• The Senographe Pristina Platform utilizes 3D + 2D acquisitions significantly increases the cancer detection rate compared to 2D alone by up to 90%, with no increase in recall rate.9
• The Pristina Platform delivers superior diagnostic accuracy compared to 2D alone for all breast densities, including dense breasts.1
• 3D technology on the Senographe Pristina Platform proven to reduce patient recall rate vs. 2D alone.8

Get in touch

Have a question? We would like to hear from you.

REFERENCES
Pristina Duo is a commercial offering of Senographe PristinaTM. All features and options may not be available in all countries. Please check with your local GE HealthCare representative for availability.

1. GE HealthCare DBT delivers superior diagnostic accuracy demonstrated in a reader study comparing 
the ROC AUC of GE HealthCare screening protocol (V-Preview + 3D CC/MLO with 3D in STD mode) to that of 2D FFDM 
alone. FDA PMA P130020. 

2. IPSOS Technologists Study sponsored by GE HealthCare, conducted with 50 users in Japan and the 
European Union, from July 2017 to April 2018.

3. IPSOS Patient Satisfaction Study sponsored by GE HealthCare, conducted with 315 patients across
2 sites in Europe, February 2017.

4. Analysis of 2,654 systems covering >2 million exams, Pristina Duo supports customers with the potential 
to image up to 150 patients a day. Results may vary according to hospital size, working days, working hours, etc. there can be no guarantee that each Pristina system will achieve the same results.

5. Analysis of the 42,543 Service requests on Pristina platform systems under Contract or Warranty from January 2022 to September 2024. Results may vary according to hospital size, working days, working hours, etc . there can be no guarantee that each Pristina system will achieve the same results.

6. IPSOS Patient Satisfaction Study sponsored by GE HealthCare, conducted with 215 patients across
1 site in Italy, February 2017.

7. Phantom measurements as of July 2024. Senographe Pristina with default value STD mode. Dose comparison based on NHS Breast Screening Programme equipment reports.
https://medphys.royalsurrey.nhs.uk/nccpm/?s=technicalreports. Systems comparison in the USA.

8. At equivalent sensitivity. Superior diagnostic accuracy demonstrated in a reader study comparing the ROC AUC of GE HealthCare screening
protocol (V-Preview + 3D CC/MLO with 3D in STD mode) to that of 2D FFDM alone. V-Preview is the 2D synthesized image generated by GE HealthCare Seno Iris mammography software from GE HealthCare DBT images. FDA PMA P130020
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P130020.

9. Digital Mammography versus Digital Mammography plus tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial.
https://pubs.rsna.org/doi/10.1148/radiol.2018172119. Applicable for Europe only.
 

JB33884XX